Wearable congestive heart failure management system

Inventors

VARADAN, VIJAYRai, PratyushOh, Se ChangKumar, Prashanth ShyamRamasamy, Mouli

Assignees

Nanowear Inc

Interested in licensing this patent?

MTEC can help explore whether this patent might be available for licensing for your application.

Publication Number

US-12138058-B2

Patent

Publication Date

2024-11-12

Expiration Date


Abstract

A non-invasive, wearable and portable medical device for evaluation and monitoring the heart condition for patients with congestive heart failure and a CHF management system is provided comprising a wearable textile-based device utilizing physiologic and biometric sensors, a Signal Acquisition Unit, and a monitoring system executing a suite of software algorithms to monitor and evaluate patients with CHF.

Core Innovation

The invention provides a non-invasive wearable textile-based congestive heart failure (CHF) management system. A wearable textile harness includes an adjustable elastic horizontal band and an adjustable elastic vertical band configured to contact a thoracic cage region around an xyphoid process, and the harness includes elastomeric compression fabric and textile-based nanosensors, including vertically standing nanofilaments.

The system includes a Signal Acquisition Unit (SAU) with analog front ends and a wireless module. The SAU collects and digitizes ECG/ICG/impedance (Zo), respiration/respiratory rate, and heart sounds, and further collects actigraphy/posture information using an inertial measurement unit (IMU).

The processing unit computes and uses a composite “SimpleSense” CHF monitoring metric for monitoring, remote evaluation, and alerting. The derived physiological parameters include atrial/ventricular activity and PR/QRS/ST-T, cardiac output and stroke volume, pulmonary/vascular pressures, minute ventilation, shortness of breath, and exercise tolerance, with wireless communication and cloud storage/database services supporting alerting to a smart phone and a web portal.

Claims Coverage

Not explicitly described in patent.

Not explicitly described in patent.

Stated Advantages

Enables remote, continuous CHF evaluation and alerting.

Provides composite “SimpleSense” CHF monitoring metric derived from multiple non-invasive physiological measurements.

Documented Applications

Remote, continuous evaluation and alerting of congestive heart failure using a smart phone and a web portal/cloud services.

Monitoring CHF using derived physiological parameters from textile-based nanosensors and an SAU, including derived cardiac and respiratory-related metrics.

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.